|
Volumn 144, Issue 10, 2008, Pages 1396-1397
|
Efalizumab-associated Guillain-Barré syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EFALIZUMAB;
IMMUNOGLOBULIN;
INSULIN;
LISINOPRIL;
METFORMIN;
PANTOPRAZOLE;
RISPERIDONE;
SUCRALFATE;
ADULT;
CASE REPORT;
CEREBROSPINAL FLUID EXAMINATION;
CERVICAL SPINE;
DEMYELINATING DISEASE;
DOWN SYNDROME;
DRUG WITHDRAWAL;
ELECTROMYOGRAM;
GUILLAIN BARRE SYNDROME;
HUMAN;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
LETTER;
LIMB WEAKNESS;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
PSORIASIS;
THORACOLUMBAR SPINE;
URINE INCONTINENCE;
ADULT;
ANTIBODIES, MONOCLONAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FOLLOW-UP STUDIES;
GUILLAIN-BARRE SYNDROME;
HUMANS;
IMMUNOGLOBULINS;
INFUSIONS, INTRAVENOUS;
MALE;
PSORIASIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 54349084042
PISSN: 0003987X
EISSN: 0003987X
Source Type: Journal
DOI: 10.1001/archderm.144.10.1396 Document Type: Letter |
Times cited : (6)
|
References (5)
|